What's new

[Cyprus Times] New major research... What genetic predisposition to coronavirus infection is associated with

cord.jpg

Genetic susceptibility to SARS-CoV-2 infection was found to increase the risk of developing hypothyroidism by 33.5%

A new study, published in the international journal Thyroid, has shown that genetic predisposition to coronavirus infection is associated with an increased risk of developing subclinical or clinical hypothyroidism.

Professors Stavroula (Lina) Paschou (Assistant Professor of Endocrinology), Melpomene Pepa (Professor of Endocrinology), Evanthia Kassis (Professor of Biochemistry-Endocrinology) of the School of Medicine of the University of Athens, Greece, Irini Lambrinoudaki (Professor of Endocrinology) and Theodora Psaltopoulou (Professor of Therapeutics-Epidemiology-Preventive Medicine) summarize the main points of this study.

This is a genome-wide association study (GWAS). The researchers evaluated data from about 1.3 million patients with COVID-19.

What the study showed

Of these, about 1.5 million were hospitalized and about 1 million had severe COVID-19. Included were about 52,000 patients with hyperthyroidism, about 53,000 patients with hypothyroidism and about 755,000 patients with autoimmune thyroid disease, about 54,000 whose thyroid-stimulating hormone (TSH) levels were normal, about 49,000 patients whose free thyroxine (FT4) levels were normal, and about 120.000 or so who had any TSH value.

Using the Mendelian randomization method to determine genetic association, the authors found that genetic susceptibility to SARS-CoV-2 infection increased the risk of developing hypothyroidism by 33.5%. Sensitivity analyses of the association showed similar results.

The increased risk applies to both subclinical and clinical hypothyroidism. No similar results were found for hyperthyroidism. Also, no inverse association was observed, i.e. genetic predisposition to hypothyroidism was not associated with an increased risk for COVID-19.



Assuming that the incidence of hypothyroidism among individuals without COVID-19 is similar to the incidence in the European population before the COVID-19 pandemic, i.e. 220 per 100,000 person-years, the absolute risk of hypothyroidism among those with COVID-19 increases by about 80 cases per 100 cases.000 person-years compared to those without infection, if the prevalence of SARS-CoV-2 infection is doubled.

Indeed, the risk relates to genetic susceptibility to COVID-19 infection and not to the infection itself, so it increases even if the predisposed patients do not actually become infected.

Source: in.gr


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top